First third-gen artificial heart implant successful in Vietnam
The four-hour surgery was conducted by doctors from the 108 Military Central Hospital under the guidance of Professor Jan D. Schmitto, President of the Mechanical Circulatory Support (MCS) Programme and a world-renowned expert in the field.
The surgeons operated on the patient. (Photo: 108 Military Central Hospital)
Hanoi (VNA)ꦇ - Doctors at the 108 Military Central Hospital have successfully performed Vietnam’s first implantation of a third-generation partial artificial heart (LVAD – HeartMate 3).
This marks a significant milestone in the country’s medical field, bringing Vietnamese healthcare closer to the world’s most advanced systems.
A lifesaving solution for patients awaiting heart transplants
In March, 46-year-old patient H.T.X from Thanh Hoa province was diagnosed with severe heart failure with reduced ejection fraction (EF down to just 19%) caused by dilated cardiomyopathy. She also suffered from serious complications, including a previous stroke and right subclavian artery occlusion.
After extensive consultations with both domestic and international medical experts, the patient was indicated for implantation of a third-generation Left Ventricular Assist Device (LVAD – HeartMate 3), the latest model designed to support the left side of the heart.
The four-hour surgery was conducted by doctors from the 108 Military Central Hospital under the guidance of Professor Jan D. Schmitto, President of the Mechanical Circulatory Support (MCS) Programme and a world-renowned expert in the field.
Two weeks post surgery, the patient has regained stable health and is independently mobile. She is currently undergoing professional post-operative care and is expected to be discharged soon.
According to Dr. Dang Viet Duc, Deputy Director of the Cardiology Institute at 108 Military Central Hospital, the HeartMate 3 LVAD is among the most advanced cardiovascular technologies currently available. It significantly enhances blood circulation to the body’s organs, allowing patients to maintain a near-normal quality of life.
Looking forward to a new chapter
The patient undergoes a post-surgery health check-up. (Photo: 108 Military Central Hospital)
“I truly long to live and witness my son’s wedding, even though he is still a university student. I am deeply grateful to the doctors, nurses, staff at 108 Military Central Hospital, and the international experts who have ‘revived’ my heart. I feel very healthy now and eagerly await the day I am discharged,” the patient said.
Heart failure is the final stage of many cardiovascular diseases and has the highest mortality rate globally, even higher than cancer and stroke.
The successful implantation of the HeartMate 3 device, performed for the first time in Vietnam at the 108 Military Central Hospital, highlights its superior performance, which has been proven in multiple global studies showing over 76% five-year survival rates. It is currently the only LVAD recognised by major cardiology associations worldwide as a long-term treatment option for end-stage heart failure patients awaiting transplants.
This success offers new hope to thousands of patients with end-stage heart failure who have no option but to wait for a transplant, while donor organ availability remains extremely limited despite recent improvements.
This was the first successful implantation performed by a team of young Vietnamese doctors from the 108 Military Central Hospital, under international guidance. It represents a turning point in Vietnam’s cardiovascular surgery field./.
Hue Central Hospital in the central province of Thua Thien-Hue has successfully performed its 13th heart transplant, bringing life to a male patient with end-stage heart failure. The hospital also establishes a new record for heart transplants in Vietnam.
Dozens of children with severe urological birth defects and rare urological conditions in Ho Chi Minh City, Vinh, Hanoi and Da Nang are receiving free genital surgeries under the ‘Thien Nhan & Friends’ programme – a project that offers child genital reconstruction surgeries in Vietnam.
Advanced technology is transforming healthcare in Vietnam, offering cutting-edge treatment options domestically and allowing thousands of patients to undergo successful surgeries without the need to seek care abroad.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
